Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'SHORTENED SURVIVAL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 81 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Brabender, J; Danenberg, KD; Metzger, R; Schneider, PM; Park, JM; Salonga, D; Holscher, AH; Danenberg, PV
      Epidermal growth factor receptor and HER2-neu mRNA expression in non-smallcell lung cancer is correlated with survival

      CLINICAL CANCER RESEARCH
    2. Bunn, PA; Helfrich, B; Soriano, AF; Franklin, WA; Varella-Garcia, M; Hirsch, FR; Baron, A; Zeng, C; Chan, DC
      Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents

      CLINICAL CANCER RESEARCH
    3. Menard, S; Casalini, P; Campiglio, M; Pupa, S; Agresti, R; Tagliabue, E
      HER2 overexpression in various tumor types, focussing on its relationship to the development of invasive breast cancer

      ANNALS OF ONCOLOGY
    4. Steels, E; Paesmans, B; Berghmans, T; Branle, F; Lemaitre, F; Mascaux, C; Meert, AP; Vallot, F; Lafitte, JJ; Sculier, JP
      Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis

      EUROPEAN RESPIRATORY JOURNAL
    5. Junker, K
      Prognostic factors in stage I/II non-small cell lung cancer

      LUNG CANCER
    6. Soini, Y; Vakkala, M; Kahlos, K; Paakko, P; Kinnula, V
      MnSOD expression is less frequent in tumour cells of invasive breast carcinomas than in in situ carcinomas or non-neoplastic breast epithelial cells

      JOURNAL OF PATHOLOGY
    7. Rorke, S; Murphy, S; Khalifa, M; Chernenko, G; Tang, SC
      Prognostic significance of BAG-1 expression in nonsmall cell lung cancer

      INTERNATIONAL JOURNAL OF CANCER
    8. Ardizzoni, A; Cafferata, MA; Paganuzzi, M; Filiberti, R; Marroni, P; Neri, M; Fontana, V; Nicolo, G; Perdelli, L; Stampino, CG; Rosso, R; Puntoni, R
      Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma

      CANCER
    9. Vakkala, M; Kahlos, K; Lakari, E; Paakko, P; Kinnula, V; Soini, Y
      Inducible nitric oxide synthase expression, apoptosis, and angiogenesis inin situ and invasive breast carcinomas

      CLINICAL CANCER RESEARCH
    10. Mitsudomi, T; Hamajima, N; Ogawa, M; Takahashi, T
      Prognostic significance of p53 alterations in patients with non-small celllung cancer: A meta-analysis

      CLINICAL CANCER RESEARCH
    11. Oyama, T; Osaki, T; Nose, N; Ichiki, Y; Inoue, M; Imoto, H; Yoshimatsu, T; Kodate, M; Uramoto, H; Mizoue, T; Yano, K; Yasumoto, K
      Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma

      ANTICANCER RESEARCH
    12. Turunen, N; Paakko, P; Soini, Y
      Apoptosis in gallbladder carcinomas and dysplasias, its relation to the expression of caspases 3, 6 and 8 and apoptosis regulating proteins bcl-2, mcl-1 and bax

      HISTOLOGY AND HISTOPATHOLOGY
    13. Schneider, PM; Praeuer, HW; Stoeltzing, O; Boehm, J; Manning, J; Metzger, R; Fink, U; Wegerer, S; Hoelscher, AH; Roth, JA
      Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non small cell lung cancer

      BRITISH JOURNAL OF CANCER
    14. Vakkala, M; Lahteenmaki, K; Raunio, H; Paakko, P; Soini, Y
      Apoptosis during breast carcinoma progression

      CLINICAL CANCER RESEARCH
    15. Soini, Y; Kinnula, V; Kaarteenaho-Wiik, R; Kurttila, E; Linnainmaa, K; Paakko, P
      Apoptosis and expression of apoptosis regulating proteins bcl-2, mcl-1, bcl-X, and bar in malignant mesothelioma

      CLINICAL CANCER RESEARCH
    16. Komiya, T; Hirashima, T; Kawase, I
      Clinical significance of p53 in non-small cell lung cancer (Review)

      ONCOLOGY REPORTS
    17. Wu, YY; Khan, H; Chillar, R; Vadgama, JV
      Prognostic value of plasma HER-2/neu in African American and Hispanic women with breast cancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    18. Soini, Y; Paakko, P
      Apoptosis and expression of caspases 3, 6 and 8 in malignant non-Hodgkin'slymphomas

      APMIS
    19. Thomas, M; Rube, C; Semik, M; von Eiff, M; Klinke, F; Macha, HN; Freitag, L; Scheld, HH; Willich, N; Berdel, WE; Junker, K
      Trimodality therapy in stage III non-small cell lung cancer: prediction ofrecurrence by assessment of p185(neu)

      EUROPEAN RESPIRATORY JOURNAL
    20. Graziano, SL; Gamble, GP; Newman, NB; Abbott, LZ; Rooney, M; Mookherjee, S; Lamb, ML; Kohman, LJ; Poiesz, BJ
      Prognostic significance of K-ras codon 12 mutations in patients with resected stage I and II non-small-cell lung cancer

      JOURNAL OF CLINICAL ONCOLOGY
    21. Lappi-Blanco, E; Soini, Y; Paakko, P
      Apoptotic activity is increased in the newly formed fibromyxoid connectivetissue in bronchiolitis obliterans organizing pneumonia

      LUNG
    22. Fu, XL; Zhu, XZ; Shi, DR; Xiu, LZ; Wang, LJ; Zhao, S; Qian, H; Lu, HF; Xiang, YB; Jiang, GL
      Study of prognostic predictors for non-small cell lung cancer

      LUNG CANCER
    23. Vakkala, M; Paakko, P; Soini, Y
      Expression of caspases 3, 6 and 8 is increased in parallel with apoptosis and histological aggressiveness of the breast lesion

      BRITISH JOURNAL OF CANCER
    24. Keum, JS; Kong, G; Yang, SC; Shin, DH; Park, SS; Lee, JH; Lee, JD
      Cyclin D1 overexpression is an indicator of poor prognosis in resectable non small cell lung cancer

      BRITISH JOURNAL OF CANCER
    25. Tormanen, U; Nuorva, K; Soini, Y; Paakko, P
      Apoptotic activity is increased in parallel with the metaplasia-dysplasia-carcinoma sequence of the bronchial epithelium

      BRITISH JOURNAL OF CANCER
    26. PAAKKO P; RAMET M; VAHAKANGAS K; KORPELA N; SOINI Y; TURUNEN S; JAWORSKA M; GILLISSEN A
      CROCIDOLITE ASBESTOS CAUSES AN INDUCTION OF P53 AND APOPTOSIS IN CULTURED A-549 LUNG-CARCINOMA CELLS

      Apoptosis
    27. OYAMA T; OSAKI T; MITSUDOMI T; OGAWA R; NAKANISHI R; SUGIO K; YASUMOTO K
      P53 ALTERATION, PROLIFERATING CELL NUCLEAR ANTIGEN, AND NUCLEOLAR ORGANIZER REGIONS IN THYMIC EPITHELIAL TUMORS

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    28. FONTANINI G; DELAURENTIIS M; VIGNATI S; CHINE S; LUCCHI M; SILVESTRI V; MUSSI A; DEPLACIDO S; TORTORA G; BIANCO AR; GULLICK W; ANGELETTI CA; BEVILACQUA G; CIARDIELLO F
      EVALUATION OF EPIDERMAL GROWTH FACTOR-RELATED GROWTH-FACTORS AND RECEPTORS AND OF NEOANGIOGENESIS IN COMPLETELY RESECTED STAGE I-IIIA NON-SMALL-CELL LUNG-CANCER - AMPHIREGULIN AND MICROVESSEL COUNT ARE INDEPENDENT PROGNOSTIC INDICATORS OF SURVIVAL

      Clinical cancer research
    29. FONTANINI G; DELAURENTIIS M; VIGNATI S; CHINE S; LUCCHI M; SILVESTRI V; MUSSI A; DEPLACIDO S; TORTORA G; BIANCO AR; GULLICK W; ANGELETTI CA; BEVILACQUA G; CIARDIELLO F
      EVALUATION OF EPIDERMAL GROWTH FACTOR-RELATED GROWTH-FACTORS AND RECEPTORS AND OF NEOANGIOGENESIS IN COMPLETELY RESECTED STAGE I-IIIA NON-SMALL-CELL LUNG-CANCER - AMPHIREGULIN AND MICROVESSEL COUNT ARE INDEPENDENT PROGNOSTIC INDICATORS OF SURVIVAL

      Clinical cancer research
    30. GREATENS TM; NIEHANS GA; RUBINS JB; JESSURUN J; KRATZKE RA; MADDAUS MA; NIEWOEHNER DE
      DO MOLECULAR MARKERS PREDICT SURVIVAL IN NON-SMALL-CELL LUNG-CANCER

      American journal of respiratory and critical care medicine
    31. SOINI Y; RAUNIO H; PAAKKO P
      HIGH-GRADE MALIGNANT NON-HODGKINS-LYMPHOMAS DIFFER FROM LOW-GRADE LYMPHOMAS IN THE EXTENT OF APOPTOSIS AND THEIR EXPRESSION OF BCL-2, MCL-1, BAX AND P53

      Tumor biology
    32. Papahadjopoulos, D; Kirpotin, DB; Park, JW; Hong, KL; Shao, Y; Shalaby, R; Colbern, G; Benz, CC
      Targeting of drugs to solid tumors using anti-HER2 immunoliposomes

      JOURNAL OF LIPOSOME RESEARCH
    33. KWIATKOWSKI DJ; HARPOLE DH; GODLESKI J; HERNDON JE; SHIEH DB; RICHARDS W; BLANCO R; XU HJ; STRAUSS GM; SUGARBAKER DJ
      MOLECULAR PATHOLOGICAL SUBSTAGING IN 244 STAGE-I NON-SMALL-CELL LUNG-CANCER PATIENTS - CLINICAL IMPLICATIONS

      Journal of clinical oncology
    34. Vainio, H
      Use of biomarkers - new frontiers in occupational toxicology and epidemiology

      TOXICOLOGY LETTERS
    35. SOINI Y; TORMANEN U; PAAKKO P
      APOPTOSIS IS INVERSELY RELATED TO BCL-2 BUT NOT TO BAX EXPRESSION IN SALIVARY-GLAND TUMORS

      Histopathology
    36. Virkajarvi, N; Paakko, P; Soini, Y
      Apoptotic index and apoptosis influencing proteins bcl-2, mcl-1, bax and caspases 3, 6 and 8 in pancreatic carcinoma

      HISTOPATHOLOGY
    37. DZIADZIUSZKO R; JASSEM E; JASSEM J
      CLINICAL IMPLICATIONS OF MOLECULAR ABNORMALITIES IN LUNG-CANCER

      Cancer treatment reviews
    38. NEMUNAITIS J; KLEMOW S; TONG A; COURTNEY A; JOHNSTON W; MACK M; TAYLOR W; SOLANO M; STONE M; MALLAMS J; MUES G
      PROGNOSTIC VALUE OF K-RAS MUTATIONS, RAS ONCOPROTEIN, AND C-ERB B-2 ONCOPROTEIN EXPRESSION IN ADENOCARCINOMA OF THE LUNG

      American journal of clinical oncology
    39. Kim, YC; Park, KO; Kern, JA; Park, CS; Lim, SC; Jang, AS; Yang, JB
      The interactive effect of Ras, HER2, P53 and Bcl-2 expression in predicting the survival of non-small cell lung cancer patients

      LUNG CANCER
    40. MARTIN PN; RODRIGUEZ EP; BENDITO AS
      NEW PROGNOSTIC FACTORS IN BRONCHOGENIC LUNG-CANCER

      Revista Clinica Espanola
    41. CHRISTIANSON TA; DOHERTY JK; LIN YJ; RAMSEY EE; HOLMES R; KEENAN EJ; CLINTON GM
      NH2-TERMINALLY TRUNCATED HER-2 NEU PROTEIN - RELATIONSHIP WITH SHEDDING OF THE EXTRACELLULAR DOMAIN AND WITH PROGNOSTIC FACTORS IN BREAST-CANCER/

      Cancer research
    42. HAMBURGER AW; FERNANDES A; MURAKAMI M; GERWIN BI
      THE ROLE OF TRANSFORMING-GROWTH-FACTOR-ALPHA PRODUCTION AND ERBB-2 OVEREXPRESSION IN INDUCTION OF TUMORIGENICITY OF LUNG EPITHELIAL-CELLS

      British Journal of Cancer
    43. TORRE EA; SALIMBENI V; FULCO RA
      THE ERBB-2 ONCOGENE AND CHEMOTHERAPY - A MINIREVIEW

      Journal of chemotherapy
    44. NISHIO M; KOSHIKAWA T; YATABE Y; KUROISHI T; SUYAMA M; NAGATAKE M; SUGIURA T; ARIYOSHI Y; MITSUDOMI T; TAKAHASHI T; TAKAHASHI T
      PROGNOSTIC-SIGNIFICANCE OF CYCLIN D1 AND RETINOBLASTOMA EXPRESSION INCOMBINATION WITH P53 ABNORMALITIES IN PRIMARY, RESECTED NONSMALL CELLLUNG CANCERS

      Clinical cancer research
    45. FOSTER BJ; KERN JA
      HER2-TARGETED GENE-TRANSFER

      Human gene therapy
    46. OYAMA T; OSAKI T; MITSUDOMI T; MIZOUE T; OHGAMI A; NAKANISHI R; SUGIO K; YASUMOTO K
      PROLIFERATING CELL NUCLEAR ANTIGEN AND ARGYROPHILIC NUCLEOLAR ORGANIZER REGIONS IN PATIENTS WITH THYMIC DISEASE

      Oncology Reports
    47. MACKINNON M; KERR KM; KING G; KENNEDY MM; COCKBURN JS; JEFFREY RR
      P53, C-ERBB-2 AND NM23 EXPRESSION HAVE NO PROGNOSTIC-SIGNIFICANCE IN PRIMARY PULMONARY ADENOCARCINOMA

      European journal of cardio-thoracic surgery
    48. VIRKAJARVI N; PAAKKO P; SOINI Y
      ASSOCIATION BETWEEN P53 OVEREXPRESSION, CELL-PROLIFERATION, TUMOR NECROSIS AND EXTENT OF APOPTOSIS IN OPERATED PANCREATIC ADENOCARCINOMA

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    49. STRAUSS GM
      PROGNOSTIC MARKERS IN RESECTABLE NONSMALL CELL LUNG-CANCER

      Hematology/oncology clinics of North America
    50. PASTORINO U; ANDREOLA S; TAGLIABUE E; PEZZELLA F; INCARBONE M; SOZZI G; BUYSE M; MENARD S; PIEROTTI M; RILKE F
      IMMUNOCYTOCHEMICAL MARKERS IN STAGE-I LUNG-CANCER - RELEVANCE TO PROGNOSIS

      Journal of clinical oncology
    51. RODRIGUES OR; ANTONANGELO L; YAGI N; MINAMOTO H; SCHMIDT AF; CAPELOZZI VL; GOLDENBERG S; SALDIVA PHN
      PROGNOSTIC-SIGNIFICANCE OF ARGYROPHILIC NUCLEOLAR ORGANIZER REGION (AGNOR) IN RESECTED NONSMALL CELL LUNG-CANCER (NSCLC)

      Japanese Journal of Clinical Oncology
    52. REDONDO M; RODRIGUEZ F; HORTAS ML; CONCHA A; MORELL M; GARRIDO F; RUIZCABELLO F
      LACK OF CORRELATION BETWEEN CODON-12 K-RAS MUTATIONS AND MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS IN BRONCHOGENIC CARCINOMAS

      Cancer detection and prevention
    53. MUSTONEN M; RAUNIO H; PAAKKO P; SOINI Y
      THE EXTENT OF APOPTOSIS IS INVERSELY ASSOCIATED WITH BCL-2 EXPRESSIONIN PREMALIGNANT AND MALIGNANT BREAST-LESIONS

      Histopathology
    54. GRAZIANO SL
      NONSMALL CELL LUNG-CANCER - CLINICAL-VALUE OF NEW BIOLOGICAL PREDICTORS

      Lung cancer
    55. VACHTENHEIM J
      OCCURRENCE OF RAS MUTATIONS IN HUMAN LUNG-CANCER - MINIREVIEW

      Neoplasma
    56. CROWELL RE; BELINSKY SA
      GENETIC CHANGES IN LUNG-CANCER - POTENTIAL BIOMARKERS FOR EARLY DETECTION AND PREVENTION

      The Journal of laboratory and clinical medicine
    57. FUKUYAMA Y; MITSUDOMI T; SUGIO K; ISHIDA T; AKAZAWA K; SUGIMACHI K
      K-RAS AND P53 MUTATIONS ARE AN INDEPENDENT UNFAVORABLE PROGNOSTIC INDICATOR IN PATIENTS WITH NON-SMALL-CELL LUNG-CANCER

      British Journal of Cancer
    58. DIEZ M; POLLAN M; MAESTRO M; TORRES A; ORTEGA D; GOMEZ A; SANCHEZ A; HERNANDO F; BALIBREA JL
      PREDICTION OF RECURRENCE BY QUANTIFICATION OF P185(NEU) PROTEIN IN NON-SMALL-CELL LUNG-CANCER TISSUE

      British Journal of Cancer
    59. THOMAS M; JUNKER K
      ONCOGENES, DIFFERENTIATION MARKERS AND MO RPHOLOGICAL CRITERIA AS PROGNOSTIC PARAMETERS IN NONSMALL CELL BRONCHIAL-CARCINOMA

      Deutsche Medizinische Wochenschrift
    60. HSU NY; CHEN CY; WU CH; LIU TJ; KWAN PC; HSU CP; HSIA JY; CHANG WT
      DETECTION OF K-RAS POINT MUTATIONS IN CODON-12 AND CODON-13 IN NONSMALL CELL LUNG CANCERS

      Journal of the Formosan Medical Association
    61. BORGES M; SCULIER JP; PAESMANS M; RICHEZ M; BUREAU G; DABOUIS G; LECOMTE J; MICHEL J; VANCUTSEM O; SCHMERBER J; GINER V; BERCHIER MC; SERGYSELS R; MOMMEN P; KLASTERSKY J
      PROGNOSTIC FACTORS FOR RESPONSE TO CHEMOTHERAPY CONTAINING PLATINUM DERIVATIVES IN PATIENTS WITH UNRESECTABLE NONSMALL CELL LUNG-CANCER (NSCLC)

      Lung cancer
    62. ROSVOLD E
      PROGNOSTIC FACTORS FOR PATIENTS WITH NONSMALL CELL LUNG-CANCER

      Current problems in cancer
    63. GIACCONE G
      ONCOGENES AND ANTIONCOGENES IN LUNG TUMORIGENESIS

      Chest
    64. HRUSZKEWYCZ AM; DELGADO RM; KHAN MA; BENNETT WP
      SEMIAUTOMATED SEQUENCE-SPECIFIC MUTATION DETECTION OF THE HUMAN K-RASONCOGENE USING COLD SSCP ANALYSIS

      Clinical chemistry
    65. ROSELL R; MONZO M; MOLINA F; MARTINEZ E; PIFARRE A; MORENO I; MATE JL; DEANTA JM; SANCHEZ M; FONT A
      K-RAS GENOTYPES AND PROGNOSIS IN NON-SMALL-CELL LUNG-CANCER

      Annals of oncology
    66. STRAUSS GM; KWIATKOWSKI DJ; HARPOLE DH; LYNCH TJ; SKARIN AT; SUGARBAKER DJ
      MOLECULAR AND PATHOLOGICAL MARKERS IN STAGE-I NON-SMALL-CELL CARCINOMA OF THE LUNG

      Journal of clinical oncology
    67. MOUNTAIN CF
      NEW PROGNOSTIC FACTORS IN LUNG-CANCER - BIOLOGIC PROPHETS OF CANCER CELL AGGRESSION

      Chest
    68. JOHNSON BE
      BIOLOGIC AND MOLECULAR PROGNOSTIC FACTORS - IMPACT ON TREATMENT OF PATIENTS WITH NONSMALL CELL LUNG-CANCER

      Chest
    69. HARPOLE DH; HERNDON JE; WOLFE WG; IGLEHART JD; MARKS JR
      PROGNOSTIC MODEL OF RECURRENCE AND DEATH IN STAGE-I NONSMALL CELL LUNG-CANCER UTILIZING PRESENTATION, HISTOPATHOLOGY, AND ONCOPROTEIN EXPRESSION

      Cancer research
    70. NESBITT JC; PUTNAM JB; WALSH GL; ROTH JA; MOUNTAIN CF
      SURVIVAL IN EARLY-STAGE NON-SMALL-CELL LUNG-CANCER

      The Annals of thoracic surgery
    71. GAZDAR AF
      THE MOLECULAR AND CELLULAR BASIS OF HUMAN LUNG-CANCER

      Anticancer research
    72. STAHEL RA
      ANTIGENS, RECEPTORS AND DOMINANT ONCOGENES AND THE PROGNOSIS OF NONSMALL CELL LUNG-CANCER

      Lung cancer
    73. VIALLET J; AYOUB J; ROUSSEAU P; SOUHAMI L; HOHNEKER J; SHEPHERD F
      VINORELBINE (NAVELBINE) IN THE ADJUVANT AND NEOADJUVANT TREATMENT OF NONSMALL CELL LUNG-CANCER

      Seminars in oncology
    74. GAZDAR AF; BADER S; HUNG J; KISHIMOTO Y; SEKIDO Y; SUGIO K; VIRMANI A; FLEMING J; CARBONE DP; MINNA JD
      MOLECULAR-GENETIC CHANGES FOUND IN HUMAN LUNG-CANCER AND ITS PRECURSOR LESIONS

      Cold Spring Harbor Symposia on Quantitative Biology
    75. BONGIORNO PF; WHYTE RI; ORRINGER MB; BEER DG; LESSER EJ; MOORE JH; MATHISEN DJ; MCKNEALLY MF
      ALTERATIONS OF K-RAS, P53, AND ERBB-2 NEU IN HUMAN LUNG ADENOCARCINOMA/

      Journal of thoracic and cardiovascular surgery
    76. ANDERSON MLM; SPANDIDOS DA
      ONCOGENES AND ONCO-SUPPRESSOR GENES IN LUNG-CANCER

      Respiratory medicine
    77. PASTORINO U; SOZZI G; MIOZZO M; TAGLIABUE E; PILOTTI S; PIEROTTI MA
      GENETIC CHANGES IN LUNG-CANCER

      Journal of cellular biochemistry
    78. CRUMP M
      POSTOPERATIVE CHEMOTHERAPY FOR RESECTED NON-SMALL-CELL LUNG-CANCER

      World journal of surgery
    79. MITSUDOMI T; OYAMA T; KUSANO T; OSAKI T; NAKANISHI R; SHIRAKUSA T
      MUTATIONS OF THE P53 GENE AS A PREDICTOR OF POOR-PROGNOSIS IN PATIENTS WITH NON-SMALL-CELL LUNG-CANCER

      Journal of the National Cancer Institute
    80. TSAI CM; CHANG KT; PERNG RP; MITSUDOMI T; CHEN MH; KADOYAMA C; GAZDAR AF
      CORRELATION OF INTRINSIC CHEMORESISTANCE OF NON-SMALL-CELL LUNG-CANCER CELL-LINES WITH HER-2 NEU GENE-EXPRESSION BUT NOT WITH RAS GENE-MUTATIONS/

      Journal of the National Cancer Institute
    81. GAZDAR AF
      THE MOLECULAR-BIOLOGY OF LUNG-CANCER

      Tohoku Journal of Experimental Medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 15:25:52